-
GVS MedTech at DCAT Week 2026
MedTech -
Understanding the Risks of Crystalline Silica, And How to Protect Yourself.
Safety -
GVS Opens New State of the Art Facility in Lancaster, UK
Corporate -
Experience the Future of MedTech with GVS at MD&M West
MedTech -
PX5®: Setting a New Standard in Respiratory Protection
Safety -
Analysis of food samples for pesticides: why it is important to know what we put on our plates
Life Sciences -
Advanced Porous Filters for Industrial and Healthcare
MedTech -
GVS MedTech at COMPAMED 2025: Elevating Standards in Drug Administration
MedTech
-
-
GVS Opens New Manufacturing Plant in China: A New Chapter in a 15-Year Journey
Corporate -
GVS Earns EcoVadis Gold Medal for the Second Consecutive Year
ESG -
GVS Announces Strategic Acquisition of Haemonetics’ Whole Blood Business
Corporate -
Announcing the GVS 2024-2026 Sustainability Plan: "Protecting Your Tomorrow"
ESG -
GVS recognized as a Sustainability Leader 2024
ESG -
GVS is awarded the EcoVadis Gold Medal: An Achievement of Excellence in Sustainability
ESG -
Whistleblowing Reporting Channel
Corporate -
Earth likes you, like it back
Corporate -
GVS acquires 100% of the Italian Group Haemotronic
Corporate -
GVS acquires 100% of the Shanghai Transfusion Technology Co., Ltd
Corporate -
GVS acquires 100% of the RPB Group
Corporate -
First patent for 'Infusion device with air intake' registered by GVS
Corporate -
Accolade of "Cavaliere del Lavoro"
Corporate -
GVS Sud Srl collaborates in a project to develop multifunctional filters for blood treatment
Corporate -
GVS refunds the original loan of 90 million Euros in advance
Corporate -
GVS debuts on Borsa Italiana's MTA
Corporate -
GVS: IPO Ceremony at Borsa Italiana
Corporate -
GVS acquires Puerto Rico-based manufacturing operations of Haemonetics
Corporate -
GVS acquires filter product business of Graphic Controls
Corporate